We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$13.4B
AUM Growth
+$1.43B
Cap. Flow
+$857M
Cap. Flow %
6.4%
Top 10 Hldgs %
14.37%
Holding
602
New
156
Increased
172
Reduced
106
Closed
146

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$175M
2
LOW icon
Lowe's Companies
LOW
+$167M
3
AZO icon
AutoZone
AZO
+$127M
4
NTRS icon
Northern Trust
NTRS
+$127M
5
MRK icon
Merck
MRK
+$118M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$133M
2
RAI
Reynolds American Inc
RAI
+$126M
3
KEY icon
KeyCorp
KEY
+$113M
4
WMT icon
Walmart Inc
WMT
+$110M
5
OA
Orbital ATK, Inc.
OA
+$108M

Sector Composition

Rank Sector Weight
1 Technology 16.72%
2 Industrials 14.06%
3 Consumer Discretionary 12.07%
4 Healthcare 11.22%
5 Financials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSA icon
426
Public Storage
PSA
$61.3B
$795K 0.01%
+3,715
New +$768K
WT icon
427
WisdomTree
WT
$3.22B
$793K 0.01%
77,859
-23,360
-23% -$226K
CDTX
428
DELISTED
Cidara Therapeutics
CDTX
$791K 0.01%
4,884
+88
+2% +$12.5K
MAC icon
429
Macerich
MAC
$6.92B
$768K 0.01%
13,977
-7,220
-34% -$405K
ALDR
430
DELISTED
Alder Biopharmaceuticals
ALDR
$752K 0.01%
+61,414
New +$640K
RLJE
431
CALL
DELISTED
RLJ Entertainment, Inc.
RLJE
$710K 0.01%
200,000
– –
SSTI icon
432
SoundThinking
SSTI
$103M
$673K 0.01%
50,000
-50,000
-50% -$598K
KDMN
433
CALL
DELISTED
Kadmon Holdings, Inc.
KDMN
$670K 0.01%
+200,000
New +$571K
SMMT icon
434
Summit Therapeutics
SMMT
$11.1B
$628K ﹤0.01%
+50,000
New +$648K
PTLA
435
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$627K ﹤0.01%
+11,600
New +$681K
NERV icon
436
Minerva Neurosciences
NERV
$199M
$623K ﹤0.01%
10,239
-8,511
-45% -$488K
FENX
437
DELISTED
Fenix Parts, Inc.
FENX
$597K ﹤0.01%
+834,909
New +$597K
SYRE icon
438
Spyre Therapeutics
SYRE
$9.25B
$576K ﹤0.01%
4,677
+84
+2% +$7.87K
OBSV
439
DELISTED
ObsEva SA Ordinary Shares
OBSV
$556K ﹤0.01%
68,339
+1,221
+2% +$9.29K
KIM icon
440
Kimco Realty
KIM
$16.4B
$528K ﹤0.01%
27,003
-52,150
-66% -$1.02M
NTBL
441
CALL
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$508K ﹤0.01%
2,381
– –
ATXS
442
DELISTED
Astria Therapeutics
ATXS
$464K ﹤0.01%
3,645
+65
+2% +$5.42K
VLRX
443
DELISTED
VALERITAS HOLDINGS INC
VLRX
$459K ﹤0.01%
7,085
-194
-3% -$17.9K
RNGR icon
444
Ranger Energy Services
RNGR
$377M
$384K ﹤0.01%
+26,100
New +$373K
TBCH
445
Turtle Beach Corp
TBCH
$277M
$373K ﹤0.01%
112,424
+2,008
+2% +$5.87K
TCON
446
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$308K ﹤0.01%
488
+8
+2% +$4.17K
SECO
447
DELISTED
Secoo Holding Limited ADR
SECO
$295K ﹤0.01%
+3,318
New +$321K
FSAC
448
DELISTED
Federal Street Acquisition Corp. Common Stock
FSAC
$268K ﹤0.01%
+27,450
New +$268K
PARN
449
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
$96K ﹤0.01%
+147,458
New +$96K
KALV
450
DELISTED
KalVista Pharmaceuticals
KALV
$75K ﹤0.01%
11,184
+200
+2% +$1.43K
16 17
18
19 20

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q3 2017 Portfolio in Review

As of Q3 2017, Alyeska Investment Group held 602 positions worth $13.4B, up 12% from $12B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Alyeska Investment Group deployed $857M of net new capital in Q3 2017, opening 156 new positions and adding to 172 existing holdings. Its largest new stake was AutoZone: 238,293 shares worth $142M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was AbbVie, an estimated $133M trimmed.

  • Alyeska Investment Group's largest Q3 2017 buy was AutoZone: 238,293 shares worth $142M.
  • Alyeska Investment Group added most to Texas Instruments in Q3 2017, an estimated $175M increase.
  • Alyeska Investment Group's biggest Q3 2017 reduction was AbbVie, cutting an estimated $133M.
  • Alyeska Investment Group fully exited Reynolds American Inc in Q3 2017, selling an estimated $126M.
  • Alyeska Investment Group's ten largest holdings make up 14% of its $13.4B portfolio in Q3 2017.
  • Alyeska Investment Group opened 156 new positions and closed 146 in Q3 2017.
  • Alyeska Investment Group's portfolio value rose 12% quarter-over-quarter to $13.4B.

Based on Alyeska Investment Group's 13F filing for Q3 2017, filed 14 Nov 2017.